Guy-charles Fanneau De La Horie
Bioinformatics and system biology
Ascent Management Services Pte Ltd
France
Biography
Guy-Charles Fanneau de La Horie: CEO Dr Fanneau de La Horie has over 20 years of experience in the pharmaceutical and biotechnology industries. Before joining Pherecydes Pharma, he held a number of international management roles, including posts at Schering-Plough, Biogen and IDM, in both Europe and the US. More recently, he was managing director of PathoQuest, a company developing a NGS-based infectious disease diagnostic technology. Between 2006 and 2013 he was the CEO of Neovacs and coordinated the 2010 IPO.
Research Interest
Bioinformatics and system biology
